Association of Adiponectin Level and Type 2 Diabetes Mellitus (T2DM): A Systematic Review and Meta-Analysis
Keywords:Risk Factor, Vascular Disease, Adiponectin, Diabetes
Experimental and epidemiologic evidence has accumulated that supports a beneficial role of adiponectin, a major cytokine secreted from adipocyte, in glucose metabolism. Mechanistic studies show that adiponectin improves insulin sensitivity and inflammation, important mechanisms in the development of type 2 diabetes. Method: This study is a systematic review and meta-analysis conducted to see the relationship between adiponectin levels and the incidence of type 2 diabetes mellitus. The research involved in this review was taken from journal databases, such as: Pubmed, Google Scholar, and Sage Pub. The included studies were studies involving both diabetic and non-diabetic humans, the study clearly showed blood sugar levels and adiponectin levels of the study sample. Result: Researchers included 7 reviewed studies for analysis discussing adiponectin as a risk factor for type 2 DM and related complications. Conclusion: There is an inverse relationship between adiponectin levels and the incidence of diabetes and associated vascular complications.
International Diabetes Federation. Diabetes. Brussels: IDF; 2017.
Fauci AS, Jameson JL, Kasper D, et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw-Hill Education; 2018.
Soelistijo SA, Lindarto D, Decroli E, et al. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. Jakarta: PB Perkeni; 2019.
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2016;62–9.
Yan W, Q QY, Mody N, et al. The adipokine lipocalin 2 is regulated by obesity and promote insulin resistance. Diabetes. 2007;56:2533–40.
Kriketos AD, Greenfield JR, Peake PW, et al. Inflammation, Insulin Resistance, and Adiposity. Diab Care. 2004;27:2033–40.
Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of Creaktive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671–4.
Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784–92.
Li S, Shin HJ, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–88.
How to Cite
Copyright (c) 2022 International Journal For Research In Health Sciences And Nursing (ISSN: 2208-2670)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in